AI-native radiology New Lantern offers an AI-native cloud workspace that replaces PACS, dictation, and worklist, presenting a unified platform. This creates a compelling upsell path to radiology groups seeking modernization, improved efficiency, and reduced tool fragmentation.

Series A momentum With a $19M Series A led by Benchmark and multiple product launches in 2026, there is strong investor confidence and a growing product footprint. This signals readiness to scale, making the company a lower-risk partner for larger health networks seeking proven innovation.

specialized viewer gains The introduction of Mammography and PET/CT Viewer Modes positions New Lantern to target high-value subspecialties. Sales conversations can emphasize niche workflow improvements and accuracy gains in critical imaging streams.

radiology workflow focus By streamlining speech, image viewing, and interpretation into a single cloud workspace, the solution aligns with hospital priorities around productivity, clinician satisfaction, and burnout mitigation—a strong value proposition for radiology leadership purchasing decisions.

growth readiness Headquartered in San Francisco with a mid-market employee base and substantial revenue, New Lantern is positioned to penetrate mid to large radiology groups and health systems seeking scalable, AI-enhanced radiology platforms, suggesting target segments and expansion strategies for the sales team.